BBusiness Read More Biotech stocks rally on drug innovation and M&AOctober 24, 2026 Moderna gave investors a scare as its stock plunged on Thursday. But it’s still one of the hottest…
AArtificial intelligence Read More Anthropic to invest $100 million to train AI engineer talentOctober 3, 2026 Anthropic will invest $100 million into an academy for training AI talent, working with companies to integrate artificial…
MMedication Read More Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trialOctober 1, 2026 Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose…
MMedication Read More Novo’s Wegovy pill improves weight loss after switch from injectionsSeptember 30, 2026 People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
MMedication Read More Ozempic counterfeit ring charges against Indian nationals unsealedSeptember 29, 2026 Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…
BBusiness Read More Pharma stock soars 150% on injectables deal with Wegovy maker NovoSeptember 25, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Shares in Swedish microcap stock Nanexa more…
HHealthcare Read More Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli LillySeptember 25, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
HHealthcare Read More Novo Nordisk CEO on rebuilding investor trust after backlashSeptember 24, 2026 Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
AArtificial intelligence Read More CNBC Daily Open: AI trade goes Meta after Muse launchSeptember 22, 2026 Samuel Boivin | Nurphoto | Getty Images Hello, this is Leonie Kidd coming to you from London. Welcome…
HHealthcare Read More Eli Lilly CEO David Ricks discusses GLP-1s and Medicare coverageSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…
HHealthcare Read More Lilly is ramping up future manufacturing for Foundayo obesity pillSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…
BBusiness Read More Advil-maker Haleon targets consumers on weight-loss drugsSeptember 16, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Consumer health company Haleon has achieved growing sales of…